NCT03093116 2026-05-27TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT07086833 2026-05-14The Food Environment, Microbial Cysteine Metabolism, and Cancer DisparitiesPurdue UniversityPhase NA Recruiting40 enrolled